A Prelude To Bigger Gains? Plains GP Holdings LP (PAGP), Inovalon Holdings Inc (INOV) and Myriad Genetics, Inc. (MYGN)

Posted by Saimoon May 8, 2015 0 Comment 391 views


New York, NY – GDP INSIDER  –  05/08/2014.

This article discusses three companies: Plains GP Holdings LP (NYSE:PAGP), Inovalon Holdings Inc (NASDAQ:INOV) and Myriad Genetics, Inc. (NASDAQ:MYGN)

Plains GP Holdings LP (NYSE:PAGP) enjoyed an increase of 3.55% or $0.99 yesterday to finish the day at a closing price of $28.91 on higher than average trading volume of 2.186 million compared with its three month average trading volume of 1.39 million. The stock has seen its value increase by 14.58% year to date, outperforming the S&P 500 index which is up 1.41% for the same period. With quarter earnings growth of 66.70% and RSI of 53.86, the stock has plenty of upside potential to achieve or exceed its one year price target estimate of $32.05, making it a solid hold.

Is It Now A Good Time To Invest In Plains GP Holdings LP? Make A Wise Investment Decision With Our Free PAGP Analysis.

Inovalon Holdings Inc (NASDAQ:INOV) continued to decline yesterday with the stock closing down 4.99% or $1.23 to close the day at $23.44 on much higher than average trading volume of 4.64 million, compared to its three month average trading volume of 0.912 million. The stock is down 14% year to date and has been underperforming the S&P 500 which is down only 0.02% over the same period. With the stock now down 7.17% over the last five days and RSI at 31, it is starting to look like a very good potential purchase, making it a buy at this time.

Should You Invest In Inovalon Holdings Inc Now? Click Here To See Our Investment Report On Inovalon Holdings Inc In Our Free INOV Analysis.

Myriad Genetics, Inc. (NASDAQ:MYGN) continued its recent downward trend yesterday as the stock lost 3% or $1.01 to finish the day at $32.66 with more than 1.31 million shares changing hands compared to its three month average trading volume of 0.718 million. The shares are down by 11% over the past one year and over 10% in the past one month. The 52-week range is $31.56 to $40.50.  The technical indicators are not pointing to move in the stock one way or the other. However, with RSI of 38.09 and bearish MACD crossover, the stock may continue to fall in the near term. At this time, it is a risky buying opportunity, but one that may be worth it over the medium term.

Click Here To See How Low Myriad Genetics, Inc Can Still Go With Our Free MYGN Investment Analysis.

About Ultimate Stock Alerts

UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit www.UltimateStockAlerts.com

Disclosure:  UltimateStockAlerts.com is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment